Goldman Sachs Maintains Buy on Alkermes, Lowers Price Target to $30
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Chris Shibutani maintains a Buy rating on Alkermes (NASDAQ:ALKS) but lowers the price target from $32 to $30.
October 25, 2024 | 5:40 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Goldman Sachs has maintained its Buy rating on Alkermes but has lowered the price target from $32 to $30, indicating a slight decrease in expected valuation.
The maintenance of a Buy rating suggests continued confidence in Alkermes' performance, but the lowered price target indicates a slight reduction in expected future valuation. This could lead to neutral short-term price movement as the positive Buy rating is offset by the lower target.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100